Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311180003> ?p ?o ?g. }
- W4311180003 endingPage "10" @default.
- W4311180003 startingPage "5" @default.
- W4311180003 abstract "In spite of the great success of immune checkpoint inhibitors in immune-oncology therapy, an urgent need still exists to identify alternative approaches to broaden the scope of therapeutic coverage. Hematopoietic progenitor kinase 1 (HPK1), also known as MAP4K1, functions as a negative regulator of activation signals generated by the T cell antigen receptor. Herein we report the discovery of novel pyrazolopyridine derivatives as selective inhibitors of HPK1. The structure–activity relationship campaign led to the discovery of compound 16, which has shown promising enzymatic and cellular potency with encouraging kinome selectivity. The outstanding pharmacokinetic profiles of 16 in rats and monkeys supported further evaluations of its efficacy and safety in preclinical models." @default.
- W4311180003 created "2022-12-24" @default.
- W4311180003 creator A5000577175 @default.
- W4311180003 creator A5000676761 @default.
- W4311180003 creator A5004847981 @default.
- W4311180003 creator A5009979953 @default.
- W4311180003 creator A5023344916 @default.
- W4311180003 creator A5024142927 @default.
- W4311180003 creator A5025195017 @default.
- W4311180003 creator A5030064573 @default.
- W4311180003 creator A5030266513 @default.
- W4311180003 creator A5036303735 @default.
- W4311180003 creator A5041230347 @default.
- W4311180003 creator A5044882995 @default.
- W4311180003 creator A5061474239 @default.
- W4311180003 creator A5061537073 @default.
- W4311180003 creator A5065651204 @default.
- W4311180003 creator A5070888985 @default.
- W4311180003 creator A5077419505 @default.
- W4311180003 creator A5081541931 @default.
- W4311180003 creator A5084386900 @default.
- W4311180003 creator A5088146420 @default.
- W4311180003 date "2022-12-12" @default.
- W4311180003 modified "2023-10-18" @default.
- W4311180003 title "Discovery of Pyrazolopyridine Derivatives as HPK1 Inhibitors" @default.
- W4311180003 cites W1547957575 @default.
- W4311180003 cites W161910285 @default.
- W4311180003 cites W1983917564 @default.
- W4311180003 cites W1994993231 @default.
- W4311180003 cites W2005913148 @default.
- W4311180003 cites W2040569532 @default.
- W4311180003 cites W2051303299 @default.
- W4311180003 cites W2791483720 @default.
- W4311180003 cites W2895159427 @default.
- W4311180003 cites W2925294180 @default.
- W4311180003 cites W3081763916 @default.
- W4311180003 cites W3084281435 @default.
- W4311180003 cites W3119209177 @default.
- W4311180003 cites W3131464005 @default.
- W4311180003 cites W3135897650 @default.
- W4311180003 cites W3138776687 @default.
- W4311180003 cites W3158348874 @default.
- W4311180003 cites W4200188518 @default.
- W4311180003 doi "https://doi.org/10.1021/acsmedchemlett.2c00238" @default.
- W4311180003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36655125" @default.
- W4311180003 hasPublicationYear "2022" @default.
- W4311180003 type Work @default.
- W4311180003 citedByCount "0" @default.
- W4311180003 crossrefType "journal-article" @default.
- W4311180003 hasAuthorship W4311180003A5000577175 @default.
- W4311180003 hasAuthorship W4311180003A5000676761 @default.
- W4311180003 hasAuthorship W4311180003A5004847981 @default.
- W4311180003 hasAuthorship W4311180003A5009979953 @default.
- W4311180003 hasAuthorship W4311180003A5023344916 @default.
- W4311180003 hasAuthorship W4311180003A5024142927 @default.
- W4311180003 hasAuthorship W4311180003A5025195017 @default.
- W4311180003 hasAuthorship W4311180003A5030064573 @default.
- W4311180003 hasAuthorship W4311180003A5030266513 @default.
- W4311180003 hasAuthorship W4311180003A5036303735 @default.
- W4311180003 hasAuthorship W4311180003A5041230347 @default.
- W4311180003 hasAuthorship W4311180003A5044882995 @default.
- W4311180003 hasAuthorship W4311180003A5061474239 @default.
- W4311180003 hasAuthorship W4311180003A5061537073 @default.
- W4311180003 hasAuthorship W4311180003A5065651204 @default.
- W4311180003 hasAuthorship W4311180003A5070888985 @default.
- W4311180003 hasAuthorship W4311180003A5077419505 @default.
- W4311180003 hasAuthorship W4311180003A5081541931 @default.
- W4311180003 hasAuthorship W4311180003A5084386900 @default.
- W4311180003 hasAuthorship W4311180003A5088146420 @default.
- W4311180003 hasConcept C104317684 @default.
- W4311180003 hasConcept C184235292 @default.
- W4311180003 hasConcept C185592680 @default.
- W4311180003 hasConcept C199360897 @default.
- W4311180003 hasConcept C203014093 @default.
- W4311180003 hasConcept C2777701055 @default.
- W4311180003 hasConcept C2778012447 @default.
- W4311180003 hasConcept C2780851360 @default.
- W4311180003 hasConcept C41008148 @default.
- W4311180003 hasConcept C54174078 @default.
- W4311180003 hasConcept C55493867 @default.
- W4311180003 hasConcept C60644358 @default.
- W4311180003 hasConcept C6929976 @default.
- W4311180003 hasConcept C70721500 @default.
- W4311180003 hasConcept C71924100 @default.
- W4311180003 hasConcept C74187038 @default.
- W4311180003 hasConcept C86803240 @default.
- W4311180003 hasConcept C8891405 @default.
- W4311180003 hasConcept C98274493 @default.
- W4311180003 hasConceptScore W4311180003C104317684 @default.
- W4311180003 hasConceptScore W4311180003C184235292 @default.
- W4311180003 hasConceptScore W4311180003C185592680 @default.
- W4311180003 hasConceptScore W4311180003C199360897 @default.
- W4311180003 hasConceptScore W4311180003C203014093 @default.
- W4311180003 hasConceptScore W4311180003C2777701055 @default.
- W4311180003 hasConceptScore W4311180003C2778012447 @default.
- W4311180003 hasConceptScore W4311180003C2780851360 @default.
- W4311180003 hasConceptScore W4311180003C41008148 @default.
- W4311180003 hasConceptScore W4311180003C54174078 @default.